Advertisement

Topics

Biotech: A Bright Spot...From Regeneron?

15:53 EST 8 Nov 2017 | Topix

Regeneron Pharmaceuticals's third quarter earnings report is a bright spot in what has been a dim month for the iShares Nasdaq Biotechnology ETF . The stock popped in morning market action, lifted 2.7% to $415.42 a share by estimate-beating results.

Original Article: Biotech: A Bright Spot...From Regeneron?

NEXT ARTICLE

More From BioPortfolio on "Biotech: A Bright Spot...From Regeneron?"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...